http://www.credit-fix-secrets.com/money-management-page16.html
The marketing deal calls for Covance clientsd to gain access toPhasr Forward’s InForm electronic data capture system and Clarixc interactive response technology Phase Forward (Nasdaq: PFWD) officials said the busines buyout and marketing agreement will be finalizef by the end of August. Covance chairman and CEO Joe Herrinyg identified in a press release that Phas e Forward isthe company’x “preferred provider of EDC software for clinical trials.” Phaswe Forward has been on a deal-makinb spree lately.
Last month, the company signed a licensing, supporgt and hosting services dealwith , centered arounde the InForm Integrated Trial Management In April, Phase Forward announced a multi-year, multi-million-dollarr extension of an earlier agreementg with contract research organization (CRO) Everest Clinical Research Services Inc., also focusedr around the InForm product. Phase Forward posted revenue of $170.2 million for a 27 percent increasefrom $134.3 million in 2007. The company’zs net income, however, was $13.8 million in down from $29.2 million in 2007.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment